Lupus anticoagulant hypoprothrombinemia syndrome associated with bilateral adrenal haemorrhage in a child: early diagnosis and intervention.
Adrenal haemorrhage
Adrenal insufficiency
Hypoprothrombinemia
Lupus anticoagulant
Lupus anticoagulant hypoprothrombinemia syndrome
Journal
Thrombosis journal
ISSN: 1477-9560
Titre abrégé: Thromb J
Pays: England
ID NLM: 101170542
Informations de publication
Date de publication:
17 Mar 2021
17 Mar 2021
Historique:
received:
01
09
2020
accepted:
09
03
2021
entrez:
18
3
2021
pubmed:
19
3
2021
medline:
19
3
2021
Statut:
epublish
Résumé
Lupus anticoagulant-hypoprothrombinemia syndrome (LAHPS) is characterized by bleeding and thrombosis in patients with autoimmune diseases or infections. Paediatric LAHPS exhibits various degrees of bleeding, ranging from mild to severe; however, adrenal haemorrhage due to LAHPS and its long-term clinical course have not been sufficiently described. A 9-year-old boy presented with prolonged abdominal pain and abnormal coagulation screening tests. The laboratory tests showed prolonged activated partial thromboplastin time and subsequently revealed the presence of lupus anticoagulant, anti-nuclear antibodies, and hypoprothrombinemia, leading to diagnosis of LAHPS. An enhanced computed tomogram demonstrated nodular lesions in the adrenal glands bilaterally, suggestive of adrenal haemorrhage. Laboratory and clinical manifestations exhibited life-threatening adrenal insufficiency that required hydrocortisone administration. The patient developed systemic lupus erythematosus, diagnosed 12 months later. This patient with LAHPS developed rare adrenal failure due to adrenal haemorrhage, a life-threatening event that should be recognized and treated early. In our case, renal dysfunction was also observed when systemic lupus erythematosus was diagnosed 1 year after LAHPS. Our case emphasizes that early recognition of adrenal failure and careful long-term observation is required in patients with autoantibodies.
Sections du résumé
BACKGROUND
BACKGROUND
Lupus anticoagulant-hypoprothrombinemia syndrome (LAHPS) is characterized by bleeding and thrombosis in patients with autoimmune diseases or infections. Paediatric LAHPS exhibits various degrees of bleeding, ranging from mild to severe; however, adrenal haemorrhage due to LAHPS and its long-term clinical course have not been sufficiently described.
CASE PRESENTATION
METHODS
A 9-year-old boy presented with prolonged abdominal pain and abnormal coagulation screening tests. The laboratory tests showed prolonged activated partial thromboplastin time and subsequently revealed the presence of lupus anticoagulant, anti-nuclear antibodies, and hypoprothrombinemia, leading to diagnosis of LAHPS. An enhanced computed tomogram demonstrated nodular lesions in the adrenal glands bilaterally, suggestive of adrenal haemorrhage. Laboratory and clinical manifestations exhibited life-threatening adrenal insufficiency that required hydrocortisone administration. The patient developed systemic lupus erythematosus, diagnosed 12 months later.
CONCLUSIONS
CONCLUSIONS
This patient with LAHPS developed rare adrenal failure due to adrenal haemorrhage, a life-threatening event that should be recognized and treated early. In our case, renal dysfunction was also observed when systemic lupus erythematosus was diagnosed 1 year after LAHPS. Our case emphasizes that early recognition of adrenal failure and careful long-term observation is required in patients with autoantibodies.
Identifiants
pubmed: 33731125
doi: 10.1186/s12959-021-00271-0
pii: 10.1186/s12959-021-00271-0
pmc: PMC7968225
doi:
Types de publication
Journal Article
Langues
eng
Pagination
19Références
Case Rep Pathol. 2017;2017:1936282
pubmed: 28536665
Lupus. 2015 Jun;24(7):736-45
pubmed: 25391540
J Autoimmun. 2017 Sep;83:95-112
pubmed: 28739356
Thromb J. 2005 Apr 18;3(1):6
pubmed: 15836793
J Thromb Haemost. 2009 Oct;7(10):1737-40
pubmed: 19624461
Hamostaseologie. 2020 Aug;40(3):301-310
pubmed: 32726825
Arthritis Rheum. 2012 Aug;64(8):2677-86
pubmed: 22553077
Int J Hematol. 2017 Feb;105(2):174-183
pubmed: 27730530
Saudi Med J. 2018 Aug;39(8):829-833
pubmed: 30106422
Expert Rev Clin Immunol. 2019 Jan;15(1):73-81
pubmed: 30381978
Int J Hematol. 2019 Aug;110(2):197-204
pubmed: 31165409
Blood. 1983 Apr;61(4):684-92
pubmed: 6403077
Lupus. 2010 Nov;19(13):1520-6
pubmed: 20685773
Medicine (Baltimore). 2012 Sep;91(5):251-260
pubmed: 22932789
Rheumatol Int. 2018 Oct;38(10):1933-1940
pubmed: 30099593
J Clin Endocrinol Metab. 2013 Aug;98(8):3179-89
pubmed: 23783099